Literature DB >> 18505211

Associations of antimicrobial uses with antimicrobial resistance of fecal Escherichia coli from pigs on 47 farrow-to-finish farms in Ontario and British Columbia.

Holy T Akwar1, Cornelis Poppe, Jeff Wilson, Richard J Reid-Smith, Monica Dyck, Josh Waddington, Dayue Shang, Scott A McEwen.   

Abstract

This study assessed the associations between antimicrobial use and other management practices in pigs and antimicrobial resistance in generic Escherichia coli recovered from feces of weaner and finisher pigs on 39 purposefully selected farrow-to-finish farms in Ontario and 8 in British Columbia. Antimicrobials (n = 13), most frequently penicillins and tetracycline, wer dministered to different age groups of pigs on study farms through various routes of administration. Logistic regression was used to model risk factors to antimicrobial resistance in fecal E. coli of pigs for the following antimicrobials: ampicillin, apramycin, carbadox, cephalothin, chloramphenicol, kanamycin, neomycin, nitrofurantoin, spectinomycin, streptomycin, sulfamethoxazole tetracycline, and cotrimoxazole (trimethoprim and sulfamethoxazole). Use of antimicrobials in weaner pigs compared with use in finisher pigs was associated with resistance in most models. There was phenotypic evidence of different mechanisms of resistance selection, including direct selection [use of carbadox was associated with carbadox resistance (OR = 6.48)]; cross-resistance [use of spectinomycin was associated with streptomycin resistance (OR = 2.29)]; and possible co-selection [ceftiofu use was associated with tetracycline resistance (OR = 6.12)]. These results provide further evidence that use of antimicrobials in pigs selects for resistance among fecal E. coli within and between classes of antimicrobials.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18505211      PMCID: PMC2276907     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  17 in total

Review 1.  Use of antimicrobials in veterinary medicine and mechanisms of resistance.

Authors:  S Schwarz; E Chaslus-Dancla
Journal:  Vet Res       Date:  2001 May-Aug       Impact factor: 3.683

2.  Emergence, spread, and environmental effect of antimicrobial resistance: how use of an antimicrobial anywhere can increase resistance to any antimicrobial anywhere else.

Authors:  Thomas F O'Brien
Journal:  Clin Infect Dis       Date:  2002-06-01       Impact factor: 9.079

3.  Aminoglycoside-streptothricin resistance gene cluster aadE-sat4-aphA-3 disseminated among multiresistant isolates of Enterococcus faecium.

Authors:  G Werner; B Hildebrandt; W Witte
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

4.  Susceptibility of Escherichia coli from growing piglets receiving antimicrobial feed additives.

Authors:  L M Kim; Jeffery T Gray; Barry G Harmon; Richard D Jones; Paula J Fedorka-Cray
Journal:  Foodborne Pathog Dis       Date:  2005       Impact factor: 3.171

Review 5.  The effects of antibiotic usage in food animals on the development of antimicrobial resistance of importance for humans in Campylobacter and Escherichia coli.

Authors:  F M Aarestrup; H C Wegener
Journal:  Microbes Infect       Date:  1999-07       Impact factor: 2.700

6.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

7.  The effect of chlortetracycline treatment and its subsequent withdrawal on multi-resistant Salmonella enterica serovar Typhimurium DT104 and commensal Escherichia coli in the pig.

Authors:  A A Delsol; M Anjum; M J Woodward; J Sunderland; J M Roe
Journal:  J Appl Microbiol       Date:  2003       Impact factor: 3.772

8.  Associations among antimicrobial drug treatments and antimicrobial resistance of fecal Escherichia coli of swine on 34 farrow-to-finish farms in Ontario, Canada.

Authors:  R H Dunlop; S A McEwen; A H Meek; R C Clarke; W D Black; R M Friendship
Journal:  Prev Vet Med       Date:  1998-03-27       Impact factor: 2.670

9.  Prevalence and patterns of antimicrobial resistance of fecal Escherichia coil among pigs on 47 farrow-to-finish farms with different in-feed medication policies in Ontario and British Columbia.

Authors:  Holy T Akwar; Cornelis Poppe; Jeff Wilson; Richard J Reid-Smith; Monica Dyck; Josh Waddington; Dayue Shang; Scott A McEwen
Journal:  Can J Vet Res       Date:  2008       Impact factor: 1.310

Review 10.  Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe.

Authors:  H C Wegener; F M Aarestrup; L B Jensen; A M Hammerum; F Bager
Journal:  Emerg Infect Dis       Date:  1999 May-Jun       Impact factor: 6.883

View more
  15 in total

1.  Longitudinal study of the persistence of antimicrobial-resistant campylobacter strains in distinct Swine production systems on farms, at slaughter, and in the environment.

Authors:  Macarena P Quintana-Hayashi; Siddhartha Thakur
Journal:  Appl Environ Microbiol       Date:  2012-02-03       Impact factor: 4.792

2.  Antimicrobial resistance in fecal generic Escherichia coli and Salmonella spp. obtained from Ontario sheep flocks and associations between antimicrobial use and resistance.

Authors:  Lisa Scott; Paula Menzies; Richard J Reid-Smith; Brent P Avery; Scott A McEwen; Catherine S Moon; Olaf Berke
Journal:  Can J Vet Res       Date:  2012-04       Impact factor: 1.310

3.  Longitudinal study of distributions of similar antimicrobial-resistant Salmonella serovars in pigs and their environment in two distinct swine production systems.

Authors:  Shivaramu Keelara; H Morgan Scott; William M Morrow; Wondwossen A Gebreyes; Maria Correa; Rajesh Nayak; Rossina Stefanova; Siddhartha Thakur
Journal:  Appl Environ Microbiol       Date:  2013-06-21       Impact factor: 4.792

4.  Effect of Tetracycline Dose and Treatment Mode on Selection of Resistant Coliform Bacteria in Nursery Pigs.

Authors:  Kaare Græsbøll; Peter Damborg; Anders Mellerup; Ana Herrero-Fresno; Inge Larsen; Anders Holm; Jens Peter Nielsen; Lasse Engbo Christiansen; Øystein Angen; Shahana Ahmed; Anders Folkesson; John Elmerdahl Olsen
Journal:  Appl Environ Microbiol       Date:  2017-05-31       Impact factor: 4.792

5.  Macrolide resistance in microorganisms at antimicrobial-free Swine farms.

Authors:  Zhi Zhou; Lutgarde Raskin; Julie L Zilles
Journal:  Appl Environ Microbiol       Date:  2009-07-24       Impact factor: 4.792

6.  Associations between antimicrobial resistance phenotypes, antimicrobial resistance genes, and virulence genes of fecal Escherichia coli isolates from healthy grow-finish pigs.

Authors:  Leigh B Rosengren; Cheryl L Waldner; Richard J Reid-Smith
Journal:  Appl Environ Microbiol       Date:  2009-01-09       Impact factor: 4.792

7.  Prevalence and patterns of antimicrobial resistance of fecal Escherichia coil among pigs on 47 farrow-to-finish farms with different in-feed medication policies in Ontario and British Columbia.

Authors:  Holy T Akwar; Cornelis Poppe; Jeff Wilson; Richard J Reid-Smith; Monica Dyck; Josh Waddington; Dayue Shang; Scott A McEwen
Journal:  Can J Vet Res       Date:  2008       Impact factor: 1.310

8.  Quantifying antimicrobial resistance at veal calf farms.

Authors:  Angela B Bosman; Jaap A Wagenaar; Jaap Wagenaar; Arjan Stegeman; Hans Vernooij; Dik Mevius
Journal:  PLoS One       Date:  2012-09-07       Impact factor: 3.240

Review 9.  Antimicrobial drug use in food-producing animals and associated human health risks: what, and how strong, is the evidence?

Authors:  Karin Hoelzer; Nora Wong; Joe Thomas; Kathy Talkington; Elizabeth Jungman; Allan Coukell
Journal:  BMC Vet Res       Date:  2017-07-04       Impact factor: 2.741

10.  Development of quinoxaline 1, 4-dioxides resistance in Escherichia coli and molecular change under resistance selection.

Authors:  Wentao Guo; Haihong Hao; Menghong Dai; Yulian Wang; Lingli Huang; Dapeng Peng; Xu Wang; Hailan Wang; Min Yao; Yawei Sun; Zhenli Liu; Zonghui Yuan
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.